# Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)

> **NCT07655440** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Stanford University** · enrollment: 120 (estimated)

## Conditions studied

- Migraine Associated Vertigo
- Tinnitus
- Migraine
- Vestibular Migraine

## Interventions

- **DRUG:** Galcanezumab
- **DRUG:** Erenumab 70 mg
- **DRUG:** Eptinezumab
- **DRUG:** Atogepant
- **DRUG:** Amitriptyline
- **DRUG:** Nortriptyline
- **DRUG:** propranolol
- **DRUG:** Verapamil SR 120 mg
- **DRUG:** Candesartan
- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT07655440
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2031-07
- **Final completion:** 2031-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07655440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07655440, "Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07655440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*